Education
About Us
Working with TipRanks
Follow Us
Scancell Holdings PLC (GB:SCLP)
LSE:SCLP
SCLP Stock Chart & Stats
9.65p
0.40p(4.06%)
At close: 4:00 PM EST
9.65p
0.40p(4.06%)
Day’s Range― - ―
52-Week Range7.26p - 18.00p
Previous CloseN/A
Volume797.06K
Average Volume (3M)1.20M
Market Cap
£100.15M
Enterprise Value110.83M
Total Cash (Recent Filing)£9.10M
Total Debt (Recent Filing)£15.56M
Price to Earnings (P/E)―
Beta-0.24
Next Earnings
Jan 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,037,781,400
10 Day Avg. Volume991,653
30 Day Avg. Volume1,200,950
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Scancell Holdings News
SCLP FAQ
What was Scancell Holdings PLC’s price range in the past 12 months?
Scancell Holdings PLC lowest share price was 7.26p and its highest was 18.00p in the past 12 months.
What is Scancell Holdings PLC’s market cap?
Scancell Holdings PLC’s market cap is £100.15M.
When is Scancell Holdings PLC’s upcoming earnings report date?
Scancell Holdings PLC’s upcoming earnings report date is Jan 29, 2026 which is in 90 days.
How were Scancell Holdings PLC’s earnings last quarter?
Scancell Holdings PLC released its earnings results on Sep 11, 2025. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
Is Scancell Holdings PLC overvalued?
According to Wall Street analysts Scancell Holdings PLC’s price is currently Overvalued.
Does Scancell Holdings PLC pay dividends?
Scancell Holdings PLC does not currently pay dividends.
What is Scancell Holdings PLC’s EPS estimate?
Scancell Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scancell Holdings PLC have?
Scancell Holdings PLC has 1,037,781,400 shares outstanding.
What happened to Scancell Holdings PLC’s price movement after its last earnings report?
Scancell Holdings PLC reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 4.215%.
Which hedge fund is a major shareholder of Scancell Holdings PLC?
Currently, no hedge funds are holding shares in GB:SCLP
Scancell Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.25%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.06%
Trailing 12-Months
Company Description
Scancell Holdings PLC
Scancell Holdings (SCLP) is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer and infectious diseases. The company operates in the life sciences sector, leveraging its proprietary immunotherapy platforms, including Moditope and ImmunoBody, to create novel therapeutic products. Scancell's core products aim to stimulate the immune system to target and eradicate cancer cells more effectively, offering potentially groundbreaking treatments that address unmet medical needs.
Technical Analysis
Avacta Group plc
―
ImmuPharma
―
Oxford BioDynamics
―
Cizzle Biotechnology Holdings PLC
―
HemoGenyx Pharmaceuticals Plc
―
Options Prices
Currently, No data available
---